A Study of MHB048C in Patients With Advanced Solid Tumors

Clinical trial NCT07192120 · RECRUITING

Trial details

NCT number: NCT07192120
Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

mCRPC (Metastatic Castration-resistant Prostate Cancer)Advanced Malignant Solid Tumor

Start date: 2026-01-16
Primary completion: 2029-10-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.